Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer

dc.contributor.author	Lustberg, M.
dc.contributor.author	Wu, X.
dc.contributor.author	Fernández Martínez, Juan Luis
dc.contributor.author	Andrés Galiana, Enrique Juan de
dc.contributor.author	Philips, S.
dc.contributor.author	Leibowitz, J.
dc.contributor.author	Schneider, B.
dc.contributor.author	Sonis, S.
dc.date.accessioned	2023-08-28T09:41:52Z
dc.date.available	2023-08-28T09:41:52Z
dc.date.issued	2023
dc.identifier.citation	Supportive Care in Cancer, 31(3), (2023); doi:10.1007/s00520-023-07617-6
dc.identifier.issn	0941-4355
dc.identifier.uri	https://hdl.handle.net/10651/69398
dc.description.sponsorship	This work was supported by grants from Division of Cancer Prevention, National Cancer Institute (R01CA238946-02).
dc.language.iso	eng
dc.relation.ispartof	Supportive Care in Cancer
dc.rights	© 2023, The author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85148678327&doi=10.1007%2fs00520-023-07617-6&partnerID=40&md5=18617c73ab662c8c7b65cf388f049ada
dc.title	Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer
dc.type	journal article
dc.identifier.doi	10.1007/s00520-023-07617-6
dc.relation.publisherversion	http://dx.doi.org/10.1007/s00520-023-07617-6

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.